Mailed FIT Kits for Colorectal Cancer Screening

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Southern California

Disqualifiers: Under 60, Over 74, Incarcerated, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

1700 Participants Needed

Trial Summary

What is the purpose of this trial?

This study aims to assess whether sending patients in a county health care system additional FIT Kits can increase the FIT Kit return rate enough to warrant the extra cost. To do this, the health system mailed a random subset of patients ages 60 to 75 a FIT Kit in November 2024 in addition to sending patients an annual FIT Kit mailing. This work analyzes the return rate of mailed FIT Kits within 60-days of the November mailing.

Eligibility Criteria

This trial is for individuals aged 60 to 75 within a county health care system who are due for colorectal cancer screening. The study specifically looks at whether sending these patients an extra FIT Kit can improve the return rates for testing.

Inclusion Criteria

I am between 60 and 74 years old.

I am due for a colorectal cancer screening.

Not sent a FIT Kit in the past 3 months

Exclusion Criteria

I am either younger than 60 or older than 74.

Incarcerated

Sent a FIT Kit in the past 3 months

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive an additional mailed FIT Kit in November 2024

2 months

No in-person visits required

Follow-up

Participants are monitored for the return rate of the FIT Kits within 60 days of mailing

60 days

Treatment Details

Interventions

• Mailed Additional FIT Kit

Trial Overview The intervention being tested is the mailing of an additional FIT Kit to see if it increases the rate at which patients complete and return their kits. Patients are randomly chosen to either receive this extra kit or continue with usual care, which involves annual FIT Kit mailings.

Participant Groups

Group I: Mailed Additional FIT Kit Experimental Treatment 1 Intervention

This arm was sent a follow-up FIT Kit in November 2024 in addition to the annual FIT Kit mailing.

Group II: Usual Care (Annual FIT Kit Only) Active Control 1 Intervention

This arm was sent an annual FIT Kit but was not sent a follow-up FIT Kit in November 2024.

Who Is Running the Clinical Trial?

University of Southern California

Lead Sponsor

Trials

956

Recruited

1,609,000+